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Polymorphic ventricular tachycardia can be a detrimental
consequence of coronary vasospasm [1]. The pathophys-
iology of vasospastic angina (VA) is poorly understood,
although the disease has been linked to sympathetic hyper-
activity [2–4]. We present a 52-year-old male smoker with
ventricular fibrillation (VF) 2 years ago. Work-up revealed
no signs of structural heart disease or obstructive coronary
Fig. 1 Methylergometrine test-
ing revealed severe coronary
spasms in multiple coronary
segments resulting in ventricu-
lar tachycardia and haemody-
namic collapse (a). This quickly
resolved after intracoronary
nitrates (b)
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disease. We implanted an implantable cardioverter defib-
rillator (ICD). Several episodes of non-sustained polymor-
phic ventricular tachycardia and ICD shocks due to VF en-
sued, despite maintenance therapy with isosorbide 100 mg,
metoprolol 50 mg, verapamil 300 mg, amiodarone 200 mg.
Methylergometrine testing confirmed VA as the cause of
VF (Fig. 1a,b). To reduce sympathetic hyperactivity, bi-
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lateral renal denervation was performed using the ReCor
Paradise system. The patient remained free from episodes
of angina and ventricular arrhythmias at 6 and 12 months.
Ambulatory blood pressure and mean heart rate remained
stable between baseline and 6 months (108/60 mm Hg vs.
113/71 mm Hg and 60 bpm vs. 60 bpm, respectively). Renal
denervation could be a safe and effective treatment for nor-
motensive patients with severe VA despite optimal medical
therapy.
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